Part I : The Business Culture of Science
Since 2000, there has been a 20-fold increase* in research funding for anti-aging medicine. Wow! That’s a good thing. But let’s keep our eyes on the ball. There is danger that this welcome infusion of capital may be biasing research priorities toward those that are most likely to be profitable, and maybe even diverting the best researchers from the radical thinking that will change our understanding of biology.
Whoever discovers an effective age-reversal treatment is destined to become a multi-billionaire!
At first blush, this statement seems obvious, but that doesn’t mean it’s true. There are
If our reporting has informed or inspired you, please consider making a donation. Every contribution, no matter the size, empowers us to continue delivering accurate, engaging, and trustworthy science and medical news. Independent journalism requires time, effort, and resources—your support ensures we can keep uncovering the stories that matter most to you.
Join us in making knowledge accessible and impactful. Thank you for standing with us!